Several cancer and developmental studies have suggested a role for Akt3 in cellular migration, and demonstrated that the downregulation of Akt3 increases migration and metastasis, and MAP-2+ neurons in neurospheres expressing Akt3 with a specific mutation at E17K, have a defect in migration (42, 43). This evidence concerns the gene AKT3 and cancer.